Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chawangwa Modongo

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|July 27, 2016
Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis PatientsChawangwa Modongo, Jotam G Pasipanodya, Beki T Magazi, et al.
BMC Infectious Diseases|May 11, 2015
Erratum: Longer hospital stay is associated with high rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan AfricaNicola M Zetola, Nenad Macesic, Sanghyuk S Shin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2025
HIV status is not associated with SARS-CoV-2 viral load and longer duration of infection among people with well-controlled HIV and high COVID-19 vaccine coverageDidhiti Deb, Mohammad Eghbal Heidari, Balladiah Kizito, et al.
The Journal of Infectious Diseases|January 21, 2014
Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility testsNicola M Zetola, Chawangwa Modongo, Patrick K Moonan, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
SARS-CoV-2 Evolution in an HIV-Endemic Setting: A Genomic Epidemiology Study from BotswanaXuhua Geng, Ivan Barilar, Monamodi Kesamang, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2017
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TBChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Plos One|November 3, 2017
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activationChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
BMC Infectious Diseases|July 23, 2014
Longer hospital stay is associated with higher rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan AfricaNicola M Zetola, Nenad Macesic, Sanghyuk S Shin, et al.
Clinical Nursing Research|October 26, 2022
Depression, Anxiety, and Cigarette Smoking Among Patients with TuberculosisAlexandria Jones-Patten, Qiao Wang, Keneilwe Molebatsi, et al.
Journal of Clinical Microbiology|May 3, 2014
Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomesNicola M Zetola, Sanghyuk S Shin, Kefentse A Tumedi, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|July 27, 2016
Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis PatientsChawangwa Modongo, Jotam G Pasipanodya, Beki T Magazi, et al.
BMC Infectious Diseases|May 11, 2015
Erratum: Longer hospital stay is associated with high rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan AfricaNicola M Zetola, Nenad Macesic, Sanghyuk S Shin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2025
HIV status is not associated with SARS-CoV-2 viral load and longer duration of infection among people with well-controlled HIV and high COVID-19 vaccine coverageDidhiti Deb, Mohammad Eghbal Heidari, Balladiah Kizito, et al.
The Journal of Infectious Diseases|January 21, 2014
Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility testsNicola M Zetola, Chawangwa Modongo, Patrick K Moonan, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
SARS-CoV-2 Evolution in an HIV-Endemic Setting: A Genomic Epidemiology Study from BotswanaXuhua Geng, Ivan Barilar, Monamodi Kesamang, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2017
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TBChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Plos One|November 3, 2017
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activationChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
BMC Infectious Diseases|July 23, 2014
Longer hospital stay is associated with higher rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan AfricaNicola M Zetola, Nenad Macesic, Sanghyuk S Shin, et al.
Clinical Nursing Research|October 26, 2022
Depression, Anxiety, and Cigarette Smoking Among Patients with TuberculosisAlexandria Jones-Patten, Qiao Wang, Keneilwe Molebatsi, et al.
Journal of Clinical Microbiology|May 3, 2014
Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomesNicola M Zetola, Sanghyuk S Shin, Kefentse A Tumedi, et al.
Pageof 6